CONNECT WITH US:
Malaysia Permission Granted for COVID-19 Test Kit from China for Emergency Use; Homegrown Holista Colltech Receives Initial Order for 15,000 Units for Deployment
Jun 18, 2021 14:00 JST
Holista Colltech Limited ("Holista"), a natural wellness and health products specialist headquartered in Petaling Jaya and listed on the Australian Securities Exchange ("ASX: HCT"), said the Hecin(TM) 2019-nCOV diagnostic test kits will be used to detect the presence of the SARS-CoV-2 viral antigen from nasal swabs within 15 minutes.
US Tests Confirm Path-Away(R) Organically Kills SARS-CoV-2 Virus
Oct 21, 2020 21:00 JST
A leading US lab has released results confirming Path-Away®, a plant-based active ingredient that contains no chemicals or alcohol, can kill the virus that causes COVID-19 within two minutes. Path-Away's Anti Pathogenic Aerosol Solution was tested on SARS-CoV-2 by Microbac Laboratories, Inc., accredited by the U.S. Dept of Defence (DoD) and the Environmental Laboratory Accreditation Program (ELAP).
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
Oct 01, 2020 15:00 JST
Holista Colltech Limited (ASX: HCT, "Holista") and U.S. subsidiary, Holista Foods Inc., have entered into an agreement with leading U.S. breadmaker, Costanzo's Bakery, Inc. ("Costanzo's"), to manufacture the world's lowest Glycaemic Index (GI) clean label white bread using all-natural ingredients.
Path-Away(R), Active Ingredient in Plant-Based, Alcohol-Free NatShield(TM) Hand Sanitiser by Holista CollTech, Tested >99.99% Effective against COVID-19 Surrogate
Apr 21, 2020 06:30 JST
Path-Away(R), a plant-based natural active ingredient used in the alcohol-free NatShield(TM) hand sanitiser developed by Malaysia-based and Australia-listed Holista CollTech (ASX: HCT), has been tested by a leading U.K. bio-safety laboratory to be more than 99.99% effective against a surrogate of the COVID-19 novel coronavirus, Holista said today.
Skin Elements Enters Binding Agreement with Holista Colltech To Launch All Natural Skin-Friendly Sanitiser
Apr 03, 2020 17:00 JST
Australian-listed companies Skin Elements Limited (ASX: SKN) ('Skin Elements') and Holista Colltech Limited (ASX:HCT) ('Holista') announced today a Binding Collaboration Term Sheet (Agreement) to launch a natural alcohol-free hand sanitiser that combines Skin Elements' new skin-sensitive anti-microbial formula with the Path-Away(R) active ingredient distributed by Holista.
Holista Partners GICC LLC, the U.S. Developer of Path-Away(R), to Co-Develop Nasal Sanitising Balm for Global Markets
Feb 20, 2020 16:00 JST
Holista CollTech (ASX:HCT) ("Holista", or the Company) announced today it will co-develop and produce in Malaysia, the world's first nasal sanitising balm using Path-Away(R), a plant-based alcohol-free active ingredient that has proven to kill all previously tested corona type viruses without harming humans.
Malaysians Rush for Anti-Virus Sanitiser, NatShield(TM), after Pharmacies Restock on Concerns of Spread of Deadly Disease
Feb 06, 2020 16:00 JST
Amidst growing concerns of infection by the Wuhan coronavirus, Malaysians queued up today at local pharmacies to stock up on a handheld NatShield(TM) sanitizer containing an active ingredient that has been proven to be effective in combating over 170 deadly pathogens including previously known coronaviruses.
Orders for NatShield Sanitizer Spike after Outbreak of Coronavirus
Jan 30, 2020 16:00 JST
ASX-listed Holista CollTech (ASX:HCT, "Holista") announced today a strong spike in demand in Malaysia for it all-natural disinfectant spray NatShield(TM) Sanitizer containing the powerful Path-Away(R) anti-microbial compound. The increased demand follows the recent outbreak of the deadly coronavirus originating from Wuhan, China.
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Fat-Soluble Nutraceuticals
Dec 13, 2019 13:00 JST
Holista CollTech (ASX: HCT, Holista) today announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system.
Holista Files Patent for Water-Soluble Technology Targeting Cannabidiol (CBD) and Other High-Value, Fat-Soluble Nutraceuticals
Dec 12, 2019 12:00 JST
Holista CollTech (ASX: HCT, Holista) today announced that it has filed its 100%-owned global patent for platform technology that will deliver many fat-soluble medications by creating a water-soluble delivery system. This patented process can apply to a whole range of molecules including the Cannabidiol (CBD) oil industry.
iGalen and Holista announce resolution with ATM Metabolics
Nov 08, 2019 18:00 JST
iGalen and Holista are pleased to announce they have resolved the disputes with ATM Metabolics and its founder Dr. Joseph Ahrens, a two time Nobel prize nominee and discoverer of Emulin. As a result, they will no longer be carrying Emulin.
Malaysian Companies Develop Ingredients for World's First Healthy Bubble Tea
Oct 18, 2019 14:45 JST
Holista CollTech Ltd (Holista) and SunFresh Fruit Hub Sdn Bhd (Fruit Hub) have announced a research and development collaboration to produce three key healthy ingredients for the global Bubble Tea industry, a popular global drink fad that has raised serious concerns about its effect on diabetes and obesity.
Holista Collaborates to Develop World's First Combined Suite of Healthybubble Tea Ingredients amidst Concerns of Diabetes and Obesity
Oct 17, 2019 17:00 JST
Holista CollTech Ltd (ASX:HCT, "Holista") and SunFresh Fruit Hub Sdn Bhd ("Fruit Hub") announced today a research and development collaboration to produce three key healthy ingredients for the global Bubble Tea industry, a popular global drink fad that has raised serious concerns about its effect on diabetes and obesity.
Global BioLife unveils naturally modified Laetose at Harvard Global Catalyst Health Summit
Jul 24, 2019 15:00 JST
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce the results of clinical trials conducted on Laetose(TM), developed by its U.S. biomedical subsidiary, Global BioLife Inc. ("Global BioLife").
Global BioLife's 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Jan 28, 2019 12:00 JST
SGX-listed Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis.
Two Malaysian Companies to Develop Breakthrough Low GI Roti Canai
Jan 16, 2019 10:30 JST
Food ingredient specialist Holista CollTech Ltd (ASX:HCT, "Holista") has partnered Bursa Malaysia-listed Kawan Food Berhad ("Kawan Food") to produce healthy Asian flatbreads, including roti canai, roti and chappati, for local and international markets.
Holista Group Company signs US$6M MOU to supply Low-GI Noodle Mix to Wing's of Canada
Feb 14, 2018 17:00 JST
Holista CollTech Ltd ("Holista") (ASX: HCT) is pleased to announce group company Holista Food's Inc. ("HolistaFoods") has signed a 3-year MoU to supply its patented low glycemic index ("GI") mix to Wing's Group - North America's leading noodle supplier.
Singapore eDevelopment's Global BioLife develops Low-GI Modified Sugar
Oct 24, 2017 18:00 JST
SGX-listed Singapore eDevelopment Ltd ("SeD") announced today that its U.S. biomedical subsidiary, Global BioLife Inc. has developed a breakthrough low-calorie, low glycemic index, natural, modified sugar Laetose -- which has the potential to affect the world's sugar market.
ASX-Listed Holista and Holista Foods Inc. (USA) Develop Breakthrough Noodle Formula with Low-Glycemic Score of 38
Oct 19, 2017 16:00 JST
Australian Securities Exchange-listed food ingredient specialist Holista CollTech Ltd (ASX: HCT, "Holista") announced today that it has developed a breakthrough noodle formula certified to have a low Glycemic Index ("GI") - opening a major market for a healthier version of the staple which is vital in the global fight against diabetes and obesity.
Singapore eDevelopment's Global BioLife and Chemia Corp. to develop 3F suite of Functional Fragrances
Aug 15, 2017 19:00 JST
Singapore eDevelopment Ltd (SeD; SGX:SGE) has announced that its indirect subsidiary, Global BioLife Inc., is collaborating with U.S.-based Chemia Corporation to develop specialised fragrances which can counter mosquito-borne diseases, diminish stress and anxiety, and act in anti-viral medical applications.
Singapore eDevelopment Subsidiary Initiates Research on New Universal Drug Platform
May 22, 2017 11:00 JST
Singapore eDevelopment Limited ("SeD") subsidiary Global BioLife Inc. has initiated advanced research of a new universal therapeutic drug platform, known as Linebacker, to combat a range of diseases including Alzheimer's, diabetes and cancer.
Hitachi Rail Partners Exclusively with Intermodal Telematics to Offer a Digital Solution to Improve Rail Freight Efficiency and Safety
Jan 14, 2022 18:04 JST
DENSO Develops Global Safety Package 3 to Improve Vehicle Sensing
Jan 14, 2022 13:41 JST
TOYOTA GAZOO Racing Unveils GR GT3 Concept and GRMN Yaris as Embodiments of Making Ever-better Motorsports-bred Cars
Jan 14, 2022 12:06 JST
Lexus to Debut the NX PHEV OFFROAD Concept and Hydrogen Engine Equipped ROV Concept at the Tokyo Auto Salon
Jan 14, 2022 10:56 JST
TOYOTA GAZOO Racing Premieres GRMN Yaris in Japan
Jan 14, 2022 10:26 JST
Toyota Launches New Noah and Voxy Minivans in Japan
Jan 13, 2022 14:21 JST
Eisai to Launch Digital Too "Cogmate" in Taiwan and Hong Kong for Self-Assessment of Brain Performance (Brain Health)
Jan 13, 2022 13:26 JST
Soft Space Enters into Strategic Partnership with JCB
Jan 13, 2022 12:00 JST
Lexus Brings a Custom Tuned LX "OFFROAD" Model to the Tokyo Auto Salon 2022
Jan 12, 2022 15:32 JST
TANAKA Denshi Kogyo to Establish New Plant in Hangzhou, China
Jan 12, 2022 11:00 JST
Mitsubishi Motors to Exhibit Electric Vehicles and SUVs at Tokyo Auto Salon 2022
Jan 12, 2022 10:46 JST
JERA and MHI Start a Demonstration Project to Develop Technology to Increase the Ammonia Co-firing Rate at Coal-fired Boilers
Jan 07, 2022 15:38 JST
TOYOTA GAZOO Racing will announce challenges for making ever-better motorsports-bred cars at Tokyo Auto Salon
Jan 07, 2022 13:32 JST
Fujitsu: Notice of Product Pricing Revision in Japan
Jan 07, 2022 11:08 JST
Dongfeng Honda to Build a Dedicated Electric Vehicle Production Plant
Jan 06, 2022 13:21 JST
Eisai Enters Into Exclusive Licensing Agreement with Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator
Jan 06, 2022 11:09 JST
KT Corporation, NTT DOCOMO and Fujitsu Cooperate towards Test Facility Construction and Successful Interoperability Testing for Open RAN in Korea
Jan 06, 2022 09:24 JST
Fujitsu Reveals Technology Strategy for Sustainable Future at Fujitsu ActivateNow: Technology Summit 2022
Jan 05, 2022 10:26 JST
New Year Message from Hidehito Takahashi, Showa Denko President and CEO
Jan 04, 2022 14:00 JST
NEC Named a Major Player in IDC MarketScape
Dec 27, 2021 17:25 JST
More Latest Release >>